knowledge -WSS

knowledge

author：fashion 2025-10-01 21:47:57 - browse：5

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Global cancer cases to surge 77% by 2050, WHO report says

explore

Wikipedia

WSS

New England Journal of Medicine addresses racist history, slavery

Gene therapy for Afghan refugees’ infant will be fully covered

Heart disease and mental health: A look at cardiac psychology

Unique patient identifier: Experts argue the benefits, pitfalls

Devoted Health’s losses in Medicare Advantage persist

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

explore

knowledge

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Medicare Advantage plans can’t deny care with AI, CMS warns

Apple is now the first public company to be valued at $3 trillion

HHS names first

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Sports medicine is finally prioritizing gender equality

Idaho abortion case may prompt more restrictions in other states

How to save PrEP access — and even expand it

Three issues to watch in global health in 2024

hotspot

A protest over insulin prices is seen as a fight for life

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Bernie brings in new pharma CEOs to talk drug prices

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Three issues to watch in global health in 2024

Updated Covid vaccine has 54% effectiveness, new study suggests

explore

entertainment

Wikipedia

focus